» Articles » PMID: 37081155

Evaluating Changes to Home Bowel Cancer Screening Kits: an End-user Perspective Study

Overview
Specialties Oncology
Public Health
Date 2023 Apr 20
PMID 37081155
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Many people do not participate in mail-out bowel cancer screening programs due to difficulties using the screening kit. The current study investigated the ways the screening kit could be modified to improve usability.

Methods: 1,109 people evaluated 15 different screening kit modifications. Participants reported on how these kit modifications would affect their screening barriers, their future screening intentions, and how much they would recommend that the modification is made to the current screening kit used the program. All responses were given via an online survey conducted between April and December of 2021.

Results: Seventeen percent of previous NBCSP non-participators indicated that a one-sample test would increase their intention to participate. Recommendation ratings demonstrated higher levels of support for modifications that included providing a barcode naming label (M = 9.06, 95% CI [8.81, 9.31]), having a larger diameter opening of the collection tube (M = 8.42, 95% CI [8.10, 8.74]), and highlighting the expiry date on the kit packaging (M = 8.59, 95% CI [8.29, 8.89]). There were lower levels of support for modifications that reduced the size of the packaging the kit is sent in (M = 6.47, 95% CI [6.09, 6.85]), removed branding from kit packaging (M = 5.98, 95% CI [5.57, 6.39]), and removed the information booklet that comes with the screening kit (M = 5.25, 95% CI [4.78, 5.72]).

Conclusion: These findings highlight multiple ways in which bowel cancer screening kits can be changed to increase usability for invitees of national bowel cancer screening programs. Findings have implications for all screening programs that use immunochemical-based bowel cancer screening kits.

Citing Articles

Co-designing planning interventions to facilitate participation in mail-out bowel cancer screening.

Anderson L, Myers L, Collins K, Vicario J, Viljoen B, Ireland M BMC Public Health. 2024; 24(1):2418.

PMID: 39237922 PMC: 11375888. DOI: 10.1186/s12889-024-19867-y.

References
1.
White B, Power E, Ciurej M, Lo S, Nash K, Ormiston-Smith N . Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme. Biomed Res Int. 2015; 2015:928251. PMC: 4615211. DOI: 10.1155/2015/928251. View

2.
Oliver K, Lorenc T, Tinkler J, Bonell C . Understanding the unintended consequences of public health policies: the views of policymakers and evaluators. BMC Public Health. 2019; 19(1):1057. PMC: 6685223. DOI: 10.1186/s12889-019-7389-6. View

3.
Goodwin B, Ireland M, March S, Myers L, Crawford-Williams F, Chambers S . Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis. Syst Rev. 2019; 8(1):257. PMC: 6827213. DOI: 10.1186/s13643-019-1170-x. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Lew J, St John D, Xu X, Greuter M, Caruana M, Cenin D . Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. Lancet Public Health. 2017; 2(7):e331-e340. DOI: 10.1016/S2468-2667(17)30105-6. View